Myeloma news from the 2014 annual meeting of the American Society of Clinical Oncology has included updates on proteasome inhibitors, overcoming drug resistance, monoclonal antibodies and more. In this brief video, Dr. James Berenson, a leading myeloma researcher and physician, gives an overview with a focus on what’s important for patients today.
Launch of Myeloma BioBank
The Exciting Launch of Myeloma BioBank: James R. Berenson, MD, Multiple Myeloma, specialist announced in an interview...